Table 1. Clinicopathological data on 154 patients with endometrial endometrioid carcinoma.
| No metastasis | Metastasis | ||||
|---|---|---|---|---|---|
| n = 125 | n = 29 | ||||
| Age | 60 | (24–87) | 60 | (36–83) | |
| Parity | 2 | (0–4) | 2 | (0–3) | |
| BMI | 22.5 | (12.9–40.2) | 22.5 | (15.1–31.5) | |
| Preoperative serum CA125 level (U/mL) | 17 | (2–545) | 21 | (7–398) | |
| FIGO stage | |||||
| IA | 87 | 7 | |||
| IB | 23 | 6 | |||
| II | 13 | 2 | |||
| IIIA | 2 | 2 | |||
| IIIC | 12 | ||||
| Histological grade | |||||
| G1 | 88 | 8 | |||
| G2 | 25 | 11 | |||
| G3 | 12 | 10 | |||
| Myometrial invasion | |||||
| <1/2 | 96 | 9 | |||
| ≥1/2 | 29 | 20 | |||
| LVSI | |||||
| Negative | 75 | 6 | |||
| Positive | 50 | 23 | |||
| Median (range) | |||||
LVSI: lymph-vascular space invasion